Overview of the Investigation
Pomerantz LLP is currently investigating claims on behalf of investors of Johnson & Johnson ("J&J" or the "Company") (NYSE: JNJ). This inquiry aims to ascertain whether J&J and specific officers or directors have engaged in securities fraud or other illegal business practices that could impact investor confidence.
Recent Developments Impacting Investors
Recently, J&J made headlines by temporarily pausing certain medical procedures known as VARIPULSE™ due to reported neurovascular events. On January 8, 2025, the company announced this decision, specifying that their U.S. External Evaluation would hold off while they investigated the root causes of these events. This announcement did not sit well with investors, as J&J's stock price experienced a decline of $3.96 per share, approximately 2.71%, closing at $142.27 per share on the same day.
Pomerantz LLP's Role and Expertise
Pomerantz LLP, a well-known firm based in major cities, including New York, Chicago, and Los Angeles, prides itself on its experience in corporate, securities, and antitrust class litigation. With a legacy that started more than 85 years ago, the firm continues to uphold the standards set by its founder, Abraham L. Pomerantz, who was a pioneer in securities class actions. Pomerantz has successfully recovered substantial damages on behalf of investors affected by breaches of fiduciary duty and corporate misconduct.
Encouragement for Affected Investors
Investors who feel impacted by these recent developments are encouraged to reach out to Danielle Peyton at Pomerantz LLP. Engaging with a legal team could provide them with the necessary resources to assess their situation and consider joining a potential class action lawsuit. The focus remains on ensuring that those adversely affected by J&J's actions seek justice and potential financial recovery.
Why Are Investors Concerned?
The circumstances surrounding the temporary pause of VARIPULSE™ cases raised alarms among shareholders. Investors worry about the potential long-term impact on J&J’s financial health and market reputation.
What Should Investors Do?
Affected investors are advised to gather information and consider their legal options. Consulting with a law firm that specializes in securities matters may provide clarity and facilitate a comprehensive approach to address their concerns.
Frequently Asked Questions
What is the current status of the J&J investigation?
Pomerantz LLP is investigating whether J&J engaged in securities fraud or unlawful business practices amid recent stock price fluctuations.
How can affected investors participate in the class action?
Affected investors should contact Pomerantz LLP to explore their options for joining the class action lawsuit.
What triggered the stock price drop for J&J?
The stock price decrease followed J&J's announcement regarding the temporary halt of VARIPULSE™ procedures due to reported health incidents.
What does Pomerantz LLP specialize in?
Pomerantz LLP specializes in corporate, securities, and antitrust class litigation and has extensive experience recovering damages for investors.
How can I contact Pomerantz LLP?
Investors can reach out to Danielle Peyton at Pomerantz LLP via phone or email, as provided in their official communications.
